https://technical.ly/baltimore/wp-content/themes/national Insilico Medicine signs deal to advance use of AI in discovering new drugs - Technical.ly Baltimore

Business

Jul. 28, 2017 12:38 pm

Insilico Medicine signs deal to advance use of AI in discovering new drugs

The ETC Eastern company signed an agreement with Juvenscence to use its platform to develop new compounds. The goal is to speed up clinical trials.

Insilico Medicine relies on machine learning.

(Photo via Facebook)

Insilico Medicine has a new agreement with a British investor’s biotech company that will result in the company’s platform being used to develop new compounds for use in drugs that treat aging and age-related diseases.

The startup, which is based at ETC’s Eastern campus, signed a deal with Juvenescence AI, according to a press release. As a result, the two companies have a drug development agreement under the title Juvenescence AI Limited. Along with the deal, Juvenescence made an investment into Insilico Medicine. The amount was not disclosed.

Insilico applies machine learning to the process of drug discovery. As founder Alex Zhavoronkov told Technical.ly Baltimore, the company’s platform is designed to use deep learning techniques to analyze how a compound will affect cells. This process is currently determined through trials.

“We are excited by the potential for AI to streamline the longest and most costly portions of the drug development cycle: clinical trials,” Juvenescence Chairman Jim Mellon said in a statement. “With Insilico Medicine’s help, we hope Juvenescence AI will both develop therapeutics that treat the diseases that plague all of us as we age and eventually treat the aging process itself.”

With the deal, Juvenescence AI will license several compound families from Insilico.

-30-
JOIN THE COMMUNITY, BECOME A MEMBER
Already a member? Sign in here

Advertisement

PGDx signs a pair of partnerships as it looks to expand ‘kitted’ cancer tests

JHU spinout WindMIL Therapeutics expands to Philly, adds two new executives

Baltimore biotech company partners with JuiceBot on food safety

SPONSORED

Baltimore

Why a modern office matters for Asymmetrik’s growing culture

Baltimore, MD 21201

14 West

Solutions Specialist

Apply Now
Baltimore, MD

SmartLogic

Developer

Apply Now
Baltimore, MD 21201

Agora Financial, an Agora Company

Front End Web Developer

Apply Now

On the future of work, are you a techno-optimist or a techno-pessimist?

JHU startup PathoVax raises $2.75M, grows team

How the BioTechnical Institute of Maryland prepares Baltimore residents to work at local labs

SPONSORED

Baltimore

SmartLogic propels digital transformation aboard Baltimore Water Taxi

Baltimore, MD 21201

Agora Financial

Email Deliverability Specialist

Apply Now
Annapolis Junction, MD

Asymmetrik

FULL-STACK DEVELOPER

Apply Now
Annapolis Junction, MD

Asymmetrik

SOFTWARE ENGINEER

Apply Now

Sign-up for daily news updates from Technical.ly Baltimore

Do NOT follow this link or you will be banned from the site!